The Lazzaro Spallanzani National Institute for Infectious Diseases is an infectious disease hospital in the Italian city of Rome. The institute is named for the eighteenth-century Italian biologist Lazzaro Spallanzani. It is the Italian national reference center for Ebola patients.

During the past decade, National Institute for Infectious Diseases "L. Spallanzani" IRCCS conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Institute for Infectious Diseases "L. Spallanzani" IRCCS" #1 collaborator was "AiCuris Anti-infective Cures AG" with 1 trials as a collaborator, "Janssen, LP" with 1 trials as a collaborator, "Tel Aviv University" with 1 trials as a collaborator, "UMC Utrecht" with 1 trials as a collaborator and "University of Bristol" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "National Institute for Infectious Diseases "L. Spallanzani" IRCCS" are "HIV Infections" (3 trials), "HIV-1 Infection" (2 trials), "Acquired Immunodeficiency Syndrome" (1 trials), "Active Tuberculosis" (1 trials) and "Bacterial Resistance" (1 trials). Many other conditions were trialed in "National Institute for Infectious Diseases "L. Spallanzani" IRCCS" in a lesser frequency.

Most popular intervention types in "National Institute for Infectious Diseases "L. Spallanzani" IRCCS" are "Drug" (4 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "FTC/RPV/TDF" (2 trials), "FTC/TDF" (2 trials), "PI" (2 trials), "RTV" (2 trials) and "Stribild" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Institute for Infectious Diseases "L. Spallanzani" IRCCS" are 6 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "National Institute for Infectious Diseases "L. Spallanzani" IRCCS". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in National Institute for Infectious Diseases "L. Spallanzani" IRCCS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Institute for Infectious Diseases "L. Spallanzani" IRCCS, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

National Institute for Infectious Diseases "L. Spallanzani" IRCCS has several departments that took part in Clinical trials: "Centro di Riferimento Oncologico - Unit of Medical Oncology" - 8 trials